Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_assertion type Assertion NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_head.
- NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_assertion description "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_provenance.
- NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_assertion evidence source_evidence_literature NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_provenance.
- NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_assertion SIO_000772 20664061 NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_provenance.
- NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_assertion wasDerivedFrom befree-2016 NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_provenance.
- NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_assertion wasGeneratedBy ECO_0000203 NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_provenance.